IL-17A Levels in the Sera of Patients with Gastric Cancer Show Limited Elevation |
| |
| Abstract: | ![]()
Background: Inflammation plays a major role in the development and progression of gastric and othergastrointestinal tumors. The IL-17 family of cytokines has been under investigation as targets of immunotherapy.Materials and Methods: We investigated the levels of IL-17A inflammatory cytokine in the sera of 57 patients withgastric cancer (GC) and 90 healthy age/sex matched controls using ELISA methods. Results: In only 5 (8.8%) ofthe patients’ sera was IL-17A detectable. No IL-17A was apparent in the sera of healthy controls. The maximumconcentration of IL-17A in patients was 7.004 pg/ml. Vascular and lymphatic invasions were only seen in oneof the 5 positive cases. Although all of them were in the age group >60 years, no correlation was seen betweenage and IL-17A level. These results are somewhat different from our findings for colorectal cancer (CRC) in thesame population. Conclusions: It is possible that the inflammopathology of CRC and GC are rather different,at least in Fars, a southern province of Iran. |
| |
| Keywords: | Gastric cancer IL-17A Serum ELISA Iran |
|
| 点击此处可从《Asian Pacific journal of cancer prevention》浏览原始摘要信息 |
|
点击此处可从《Asian Pacific journal of cancer prevention》下载免费的PDF全文 |
